As bad as it may look on the charts, Moderna’s (NASDAQ: MRNA) post-COVID let-down and market reset are over. The company ...

Gold Spot US Dollar, Gold Futures, VanEck Gold Miners ETF. Read Stewart Thomson's latest article on Investing.com ...

Moderna MRNA announced fourth-quarter 2024 results. Though earnings and sales beat estimates, both metrics declined ...

In a report released today, Terence Flynn from Morgan Stanley maintained a Hold rating on Moderna (MRNA – Research Report), with a price target ...

CureVac among global top 100 most fast-paced innovators for third consecutive year in acknowledgment of its innovative strength and extensive intellectual property portfolioThe company holds one of th ...

Electric vehicle maker Tesla (TSLA) has been named the best stock for investors to short right now by Wolfe Research.Maximize ...

Reports fourth quarter revenues of $1.0 billion, GAAP net loss of $(1.1) billion and GAAP EPS of $(2.91); loss includes approximately $0.2 billion of non-cash charges related to manufacturing resizing ...

To come up with last week’s worst performers, we considered only the stocks with at least $2 billion in market capitalization ...

To illustrate that point, let's discuss two stocks in the biotech industry that have moved in opposite directions so far this ...

Below is a chart showing MRNA's trailing twelve month trading history, with the $38 strike highlighted in orange: Edison International (Symbol: EIX) options are showing a volume of 36,029 ...